Now, the regulation function of FIGNL1 on the remodeling of ECM receptor interaction pathway through HMMR further supports the indispensable role of FIGNL1 in the occurrence, progression, and treatment of HCC, laying the foundation for its use as a new target for HCC treatment. The gene discussed is FIGNL1; the disease is hepatocellular carcinoma.